OBJECTIVES: The enhanced intracellular survival (Eis) protein from Mycobacterium tuberculosis (Eis_Mtb), a regio-versatile N-acetyltransferase active towards many aminoglycosides (AGs), confers resistance to kanamycin A in some cases of extensively drug-resistant tuberculosis (XDR-TB). We assessed the activity of Eis_Mtb and of its homologue from Mycobacterium smegmatis (Eis_Msm) against a panel of anti-tuberculosis (TB) drugs and lysine-containing compounds. METHODS AND RESULTS: Both enzymes acetylated capreomycin and some lysine-containing compounds, but not other non-AG non-lysine-containing drugs tested. Modelling studies predicted the site of modification on capreomycin to be one of the two primary amines in its β-lysine side chain. Using Eis_Mtb, we established via nuclear magnetic resonance (NMR) spectroscopy that acetylation of capreomycin occurs on the ε-amine of the β-lysine side chain. Using Msm, we also demonstrated for the first time to our knowledge that acetylation of capreomycin results in deactivation of the drug. CONCLUSIONS: Eis is a unique acetyltransferase capable of inactivating the anti-TB drug capreomycin, AGs and other lysine-containing compounds.
OBJECTIVES: The enhanced intracellular survival (Eis) protein from Mycobacterium tuberculosis (Eis_Mtb), a regio-versatile N-acetyltransferase active towards many aminoglycosides (AGs), confers resistance to kanamycin A in some cases of extensively drug-resistant tuberculosis (XDR-TB). We assessed the activity of Eis_Mtb and of its homologue from Mycobacterium smegmatis (Eis_Msm) against a panel of anti-tuberculosis (TB) drugs and lysine-containing compounds. METHODS AND RESULTS: Both enzymes acetylated capreomycin and some lysine-containing compounds, but not other non-AG non-lysine-containing drugs tested. Modelling studies predicted the site of modification on capreomycin to be one of the two primary amines in its β-lysine side chain. Using Eis_Mtb, we established via nuclear magnetic resonance (NMR) spectroscopy that acetylation of capreomycin occurs on the ε-amine of the β-lysine side chain. Using Msm, we also demonstrated for the first time to our knowledge that acetylation of capreomycin results in deactivation of the drug. CONCLUSIONS: Eis is a unique acetyltransferase capable of inactivating the anti-TB drug capreomycin, AGs and other lysine-containing compounds.
Authors: Frank Peske; Andreas Savelsbergh; Vladimir I Katunin; Marina V Rodnina; Wolfgang Wintermeyer Journal: J Mol Biol Date: 2004-11-05 Impact factor: 5.469
Authors: Atefeh Garzan; Melisa J Willby; Huy X Ngo; Chathurada S Gajadeera; Keith D Green; Selina Y L Holbrook; Caixia Hou; James E Posey; Oleg V Tsodikov; Sylvie Garneau-Tsodikova Journal: ACS Infect Dis Date: 2017-02-17 Impact factor: 5.084
Authors: Melisa J Willby; Keith D Green; Chathurada S Gajadeera; Caixia Hou; Oleg V Tsodikov; James E Posey; Sylvie Garneau-Tsodikova Journal: ACS Chem Biol Date: 2016-04-07 Impact factor: 5.100
Authors: Ankita Punetha; Huy X Ngo; Selina Y L Holbrook; Keith D Green; Melisa J Willby; Shilah A Bonnett; Kyle Krieger; Emily K Dennis; James E Posey; Tanya Parish; Oleg V Tsodikov; Sylvie Garneau-Tsodikova Journal: ACS Chem Biol Date: 2020-05-18 Impact factor: 5.100